Changes in ambient temperature differentially alter the thermoregulatory, cardiac and locomotor stimulant effects of 4-methylmethcathinone (mephedrone)

Drug and Alcohol Dependence

Volumn 127, Issue 1-3, 2013, Pages 248-253

  Miller, M L ^a   Creehan, K M ^a   Angrish, D ^a   Barlow, D J ^b   Houseknecht, K L ^b   Dickerson, T J ^a   Taffe, M A ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF NEW ENGLAND   (United States)

Author keywords

Cathinone; Heart rate; Locomotor activity; Rat; Stimulant; Thermoregulation

Indexed keywords

4' METHYLMETHCATHINONE;

ANIMAL EXPERIMENT; ARTICLE; BODY TEMPERATURE; COMPARATIVE STUDY; DOSE RESPONSE; ENVIRONMENTAL TEMPERATURE; HEART RATE; HIGH TEMPERATURE; LOCOMOTION; LOW TEMPERATURE; MALE; MAXIMUM PLASMA CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; RAT; SPRAGUE DAWLEY RAT; TELEMETRY; THERMOREGULATION; TIME TO MAXIMUM PLASMA CONCENTRATION;

ANIMALS; BODY TEMPERATURE; BODY TEMPERATURE REGULATION; DOSE-RESPONSE RELATIONSHIP, DRUG; HEART RATE; MALE; METHAMPHETAMINE; MOTOR ACTIVITY; RATS; RATS, SPRAGUE-DAWLEY; STREET DRUGS; TEMPERATURE;

RATTUS; RODENTIA;

EID: 84870926382     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2012.07.003     Document Type: Article

References (29)

1. Baumann M.H., Ayestas M.A., Partilla J.S., Sink J.R., Shulgin A.T., Daley P.F., Brandt S.D., Rothman R.B., Ruoho A.E., Cozzi N.V. The designer methcathinone analogs, mephedrone and methylone, are substrates for monoamine transporters in brain tissue. Neuropsychopharmacology 2012, 37:1192-1203.
2. Bexis S., Docherty J.R. Effects of MDMA MDA and MDEA on blood pressure, heart rate, locomotor activity and body temperature in the rat involve alpha-adrenoceptors. Br. J. Pharmacol. 2006, 147:926-934.
3. Bradbury A.J., Costall B., Naylor R.J., Onaivi E.S. 5-Hydroxytryptamine involvement in the locomotor activity suppressant effects of amphetamine in the mouse. Psychopharmacology (Berl.) 1987, 93:457-465.
4. Brown P.L., Kiyatkin E.A. Brain hyperthermia induced by MDMA (ecstasy): modulation by environmental conditions. Eur. J. Neurosci. 2004, 20:51-58.
5. Camilleri A., Johnston M.R., Brennan M., Davis S., Caldicott D.G. Chemical analysis of four capsules containing the controlled substance analogues 4-methylmethcathinone, 2-fluoromethamphetamine, alpha-phthalimidopropiophenone and N-ethylcathinone. Forensic Sci. Int. 2010, 197:59-66.
6. Clark J.D., Baldwin R.L., Bayne K.A., Brown M.J., Gebhart G.F., Gonder J.C., Gwathmey J.K., Keeling M.E., Kohn D.F., Robb J.W., Smith O.A., Steggarda J.-A.D., Vandenbergh J.G., White W.J., Williams-Blangero S., VandeBerg J.L. Guide for the Care and Use of Laboratory Animals 1996, Institute of Laboratory Animal Resources, National Research Council, Washington, DC, p. 125.
7. Dafters R.I. Effect of ambient temperature on hyperthermia and hyperkinesis induced by 3,4-methylenedioxymethamphetamine (MDMA or "ecstasy") in rats. Psychopharmacology (Berl.) 1994, 114:505-508.
8. Dar K.J., McBrien M.E. MDMA induced hyperthermia: report of a fatality and review of current therapy. Intensive Care Med. 1996, 22:995-996.
9. Della Maggiore V., Ralph M.R. The effect of amphetamine on locomotion depends on the motor device utilized. The open field vs. the running wheel. Pharmacol. Biochem. Behav. 2000, 65:585-590.
10. Freedman R.R., Johanson C.E., Tancer M.E. Thermoregulatory effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans. Psychopharmacology (Berl.) 2005, 183:248-256.
11. Gilpin N.W., Wright M.J., Dickinson G., Vandewater S.A., Price J.U., Taffe M.A. Influences of activity wheel access on the body temperature response to MDMA and methamphetamine. Pharmacol. Biochem. Behav. 2011, 99:295-300.
12. Gordon C.J., Watkinson W.P., O'Callaghan J.P., Miller D.B. Effects of 3,4-methylenedioxymethamphetamine on autonomic thermoregulatory responses of the rat. Pharmacol. Biochem. Behav. 1991, 38:339-344.
13. Green A.R., Mechan A.O., Elliott J.M., O'Shea E., Colado M.I. The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy"). Pharmacol. Rev. 2003, 55:463-508.
14. Hadlock G.C., Webb K.M., McFadden L.M., Chu P.W., Ellis J.D., Allen S.C., Andrenyak D.M., Vieira-Brock P.L., German C.L., Conrad K.M., Hoonakker A.J., Gibb J.W., Wilkins D.G., Hanson G.R., Fleckenstein A.E. 4-Methylmethcathinone(mephedrone): neuropharmacological effects of a designer stimulant of abuse. J. Pharmacol. Exp. Ther. 2011, 339:530-536.
15. Huang P.-K., Aarde S.M., Angrish D., Houseknecht K.L., Dickerson T.J., Taffe M.A. Acute effects of d-methamphetamine, 3,4-methylenedioxypyrovalerone, 3,4-methylenedioxymethamphetamine, and 4-methylmethcathinone on wheel activity in rats. Drug. Alcohol Depend. 2012, (Epub ahead of print). 10.1016/j.drugalcdep.2012.05.011.
16. Iversen L., Adebowale V., Abdulrahim D., Arr-Jones G., Barnes M., Birtwistle M., Bray S., Carlin E., Clancy C., Crome I., Doran R., Gibbons S., Hargreaves P., Healy C., Hickman M., Measham F., Liddell D., Mathewson H., Pearce T., Philips J., Phillips R., Roberts H., Rowlands M., Tomlinson M., Wing A. Consideration of the Cathinones 2010, Advisory Council on the Misuse of Drugs, Washington, DC.
17. Kehr J., Ichinose F., Yoshitake S., Goiny M., Sievertsson T., Nyberg F., Yoshitake T. Mephedrone, compared with MDMA (ecstasy) and amphetamine, rapidly increases both dopamine and 5-HT levels in nucleus accumbens of awake rats. Br. J. Pharmacol. 2011, 164:1949-1958.
18. Liechti M.E., Kunz I., Kupferschmidt H. Acute medical problems due to Ecstasy use. Case-series of emergency department visits. Swiss Med. Wkly. 2005, 135:652-657.
19. Malberg J.E., Seiden L.S. Small changes in ambient temperature cause large changes in 3,4-methylenedioxymethamphetamine (MDMA)-induced serotonin neurotoxicity and core body temperature in the rat. J. Neurosci. 1998, 18:5086-5094.
20. Martinez-Clemente J., Escubedo E., Pubill D., Camarasa J. Interaction of mephedrone with dopamine and serotonin targets in rats. Eur. Neuropsychopharmacol. 2011, 22:231-236.
21. Mascola L., Dassey D., Fogleman S., Paulozzi L., Reed C.G. Ecstasy overdoses at a New Year's Eve rave-Los Angeles, California, 2010. MMWR 2010, 59:677-681.
22. Patel M.M., Belson M.G., Longwater A.B., Olson K.R., Miller M.A. Methylenedioxymethamphetamine (ecstasy)-related hyperthermia. J. Emerg. Med. 2005, 29:451-454.
23. Patel M.M., Wright D.W., Ratcliff J.J., Miller M.A. Shedding new light on the "safe" club drug: methylenedioxymethamphetamine (ecstasy)-related fatalities. Acad. Emerg. Med. 2004, 11:208-210.
24. Rockhold R.W., Carlton F.B., Corkern R., Derouen L., Bennett J.G., Hume A.S. Methcathinone intoxication in the rat: abrogation by dextrorphan. Ann. Emerg. Med. 1997, 29:383-391.
25. Schifano F., Corkery J., Naidoo V., Oyefeso A., Ghodse H. Overview of amphetamine-type stimulant mortality data-UK 1997-2007. Neuropsychobiology 2010, 61:122-130.
26. Sedefov R., Solberg U., Gallegos A., Almeida A. Europol-EMCDDA Joint Report on a New Psychoactive Substance: 4-Methylmethcathinone (Mephedrone) 2010, European Monitoring Centre for Drugs and Drug Addiction, Lisbon, Portugal.
27. Tariq M., Islam M.W., al-Meshal I.A., el-Feraly F.S., Ageel A.M. Comparative study of cathinone and amphetamine on brown adipose thermogenesis. Life Sci. 1989, 44:951-955.
28. Von Huben S.N., Lay C.C., Crean R.D., Davis S.A., Katner S.N., Taffe M.A. Impact of ambient temperature on hyperthermia induced by (+/-)3,4-methylenedioxymethamphetamine in rhesus macaques. Neuropsychopharmacology 2007, 32:673-681.
29. Winstock A.R., Mitcheson L.R., Deluca P., Davey Z., Corazza O., Schifano F. Mephedrone, new kid for the chop?. Addiction (Abingdon, England) 2011, 106:154-161.